Toxicity in chemotherapy - When less is more

New England Journal of Medicine

Volumn 366, Issue 24, 2012, Pages 2319-2320

  Laviano, Alessandro ^a   Fanelli, Filippo Rossi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B;

ADVERSE DRUG REACTION; ARTICLE; CALORIC RESTRICTION; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; CHEMOSENSITIZATION; DIET RESTRICTION; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FOOD DEPRIVATION; HUMAN; IN VIVO STUDY; MALNUTRITION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 84862183079     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr1202395     Document Type: Article

References (5)

1. Fontana L, Partridge L, Longo VD. Extending healthy life span - from yeast to humans. Science 2010;328:321-6.
2. Lee C, Raffaghello L, Brandhorst S, et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 2012;4:124ra27.
3. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-42.
4. Safdie FM, Dorff T, Quinn D, et al. Fasting and cancer treatment in humans: a case series report. Aging (Albany NY) 2009; 1:988-1007.
5. Laviano A, Seelaender M, Sanchez-Lara K, Gioulbasanis I, Molfino A, Rossi Fanelli F. Beyond anorexia-cachexia: nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy? Eur J Pharmacol 2011;668:Suppl:S87-S90.